Skip to content
drillr.ai
Sign up

ICCC

IMMUCELL CORP /DE/

NASDAQ · Healthcare · Biotechnology · US

$9.95
−0.30%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+0.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jun 22, 2026te Boekhorst Paul Francis Olivier · director, officer: President and CEOPurchase8,000$9.49
Apr 16, 2026Wainman Paul R · directorA-Award11,933$7.60
Apr 16, 2026Basse Gloria F · directorA-Award11,933$7.60
Apr 16, 2026Turner Kathy V · directorA-Award17,899$7.60
Apr 16, 2026Tomsche David Scott · directorA-Award11,933$7.60
Apr 14, 2026Brockmann Bobbi Jo · director, officer: VP of Sales and MarketingA-Award5,000$5.49
Apr 14, 2026Gathagan Bryan K. · directorA-Award10,000$5.49
Apr 14, 2026Basse Gloria F · directorA-Award10,000$5.49
Apr 14, 2026Rosgen Steven T. · directorA-Award10,000$5.49
Apr 14, 2026Tomsche David Scott · directorA-Award10,000$5.49
Apr 14, 2026Wainman Paul R · directorA-Award10,000$5.49
Mar 24, 2026BRIGHAM MICHAEL F · directorM-Exempt25,000$5.84
Mar 24, 2026BRIGHAM MICHAEL F · directorF-InKind24,052$6.07
Mar 23, 2026te Boekhorst Paul Francis Olivier · director, officer: President and CEOA-Award109,500$6.26
Jan 29, 2026te Boekhorst Paul Francis Olivier · director, officer: President and CEOA-Award110,000$6.26
Jan 29, 2026Brockmann Bobbi Jo · director, officer: VP of Sales and MarketingA-Award100,000$6.26
Jan 29, 2026Fiori Timothy C · director, officer: Chief Financial OfficerA-Award120,000$6.26
Dec 4, 2025te Boekhorst Paul Francis Olivier · director, officer: President and CEOPurchase3,598$5.04
Dec 4, 2025te Boekhorst Paul Francis Olivier · director, officer: President and CEOPurchase2,432$5.50
Dec 3, 2025te Boekhorst Paul Francis Olivier · director, officer: President and CEOPurchase3,708$4.87
Dec 3, 2025te Boekhorst Paul Francis Olivier · director, officer: President and CEOPurchase2,556$5.00
Dec 3, 2025te Boekhorst Paul Francis Olivier · director, officer: President and CEOPurchase3,521$5.04
Nov 28, 2025Tomsche David Scott · directorPurchase1,633$4.76
Nov 12, 2025te Boekhorst Paul Francis Olivier · director, officer: President and CEOA-Award74,277$6.10
Jun 13, 2025Basse Gloria F · directorM-Exempt4$4.81
Jun 13, 2025Basse Gloria F · directorM-Exempt11,470$4.81
Jun 13, 2025Basse Gloria F · directorM-Exempt3,530$4.81
Jun 12, 2025Gathagan Bryan K. · directorPurchase1,000$6.32
Apr 23, 2025Fiori Timothy C · officer: Chief Financial OfficerA-Award30,000$5.49
Sep 24, 2024Rosgen Steven T. · directorA-Award10,000$3.60
Institutional positioning

13F filings over the trailing two quarters

New 12Increased 13Reduced 12Sold out 3
FilerActionSharesFiled
VANGUARD CAPITAL MANAGEMENT LLCIncreased268,130Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position260,327May 15, 2026
MORGAN STANLEYIncreased233,910Aug 13, 2026
MORGAN STANLEYReduced221,716May 15, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased171,089Aug 13, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased151,789May 14, 2026
CRESSET ASSET MANAGEMENT, LLCUnchanged135,267May 15, 2026
Cresset Asset Management, LLCUnchanged135,267Aug 14, 2026
BLEICHROEDER LPUnchanged101,594May 14, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased72,270Aug 12, 2026
GEODE CAPITAL MANAGEMENT, LLCReduced65,765May 15, 2026
DIMENSIONAL FUND ADVISORS LPIncreased58,452Aug 11, 2026
DIMENSIONAL FUND ADVISORS LPIncreased56,030May 7, 2026
Steadtrust LLCReduced54,370Apr 15, 2026
Bleichroeder LPReduced50,000Aug 13, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 22, 2026